---
reference_id: "PMID:35608954"
title: "Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada."
authors:
- Allehebi ZO
- Khan FM
- Robbins M
- Simms E
- Xiang R
- Shawwa A
- Lindsay LR
- Dibernardo A
- "d'Entremont C"
- Crowell A
- LeBlanc JJ
- Haldane DJ
journal: Emerg Infect Dis
year: '2022'
doi: 10.3201/eid2806.220443
content_type: abstract_only
---

# Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada.
**Authors:** Allehebi ZO, Khan FM, Robbins M, Simms E, Xiang R, Shawwa A, Lindsay LR, Dibernardo A, d'Entremont C, Crowell A, LeBlanc JJ, Haldane DJ
**Journal:** Emerg Infect Dis (2022)
**DOI:** [10.3201/eid2806.220443](https://doi.org/10.3201/eid2806.220443)

## Content

1. Emerg Infect Dis. 2022 Jun;28(6):1292-1294. doi: 10.3201/eid2806.220443.

Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada.

Allehebi ZO, Khan FM, Robbins M, Simms E, Xiang R, Shawwa A, Lindsay LR, 
Dibernardo A, d'Entremont C, Crowell A, LeBlanc JJ, Haldane DJ.

In July 2021, a PCR-confirmed case of locally acquired Babesia microti infection 
was reported in Atlantic Canada. Clinical features were consistent with 
babesiosis and resolved after treatment. In a region where Lyme disease and 
anaplasmosis are endemic, the occurrence of babesiosis emphasizes the need to 
enhance surveillance of tickborne infections.

DOI: 10.3201/eid2806.220443
PMCID: PMC9155882
PMID: 35608954 [Indexed for MEDLINE]